Mobility data used to respond to COVID-19 can leave out older and non-white people
Information on individuals’ mobility–where they go as measured by their smartphones–has been used widely in devising and evaluating ways to
Read moreVaccines
New Study Shows How Mutations in SARS-CoV-2 Allow the Virus to Evade Immune System Defenses
Research reveals how mutated SARS-CoV-2 evades immune system defenses
In lab-dish experiments, the mutant virus escaped antibodies from the plasma of
COVID-19 survivors as well as pharmaceutical-grade antibodies
Mutations arose in an immunocompromised patient with chronic SARS-CoV-2 infection
Patient-derived virus harbored structural changes now seen cropping up independently in samples across the globe
Findings underscore the need for better genomic surveillance to keep track of emerging variants
Results highlight importance of therapies aimed at multiple targets on SARS-CoV-2 to minimize risk of resistance
Non-invasive skin swab samples are enough to quickly detect COVID-19, a new study finds
Researchers at the University of Surrey have found that non-invasive skin swab samples may be enough to detect COVID-19. The
Read moreDoctor communication key to pandemic vaccine adoption
PULLMAN, Wash. – People who talk with their doctors are more likely to get vaccinated during a pandemic, according to
Read moreComparative adjuvant trial evaluates Army-developed ALF in HIV vaccine regimens
The first vaccine has been administered in a comparative adjuvant trial of DNA prime/protein boost HIV vaccine regimens in Kericho, Kenya
Read moreVaccine-induced antibodies may be less effective against several new SARS-CoV-2 variants
Researchers at the Ragon Institute of MGH, MIT and Harvard and at Massachusetts General Hospital find that neutralizing antibodies raised by COVID-19 vaccines are not as effective at neutralizing some new, circulating SARS-CoV-2 variants
Read moreA general influenza vaccine
One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did
Read moreRutgers Expert Available to Discuss Coronavirus Risks a Year After Lockdowns Began
New Brunswick, N.J. (March 11, 2021) – Rutgers University–New Brunswick Professor Donald W. Schaffner is available for interviews on the likelihood of becoming infected by
Read moreHPV vaccines for adults over age 26 may not be cost-effective
Boston, MA – Vaccinating adults age 26 and older against the human papillomavirus (HPV)–the virus that causes more than 90%
Read moreImmunogenicity of Ad26.COV2.S vaccine for COVID-19
What The Study Did: In this phase 1 study, a single immunization with Ad26.COV2.S (Janssen/Johnson & Johnson) vaccine induced rapid binding
Read moreMessenger RNA COVID-19 vaccines greatly reduce risk of asymptomatic COVID-19 infection, spread to ot
ROCHESTER, Minn. — Ten days after receiving a second dose of a messenger RNA, or mRNA, vaccine for COVID-19, patients
Read moreNCCN provides new COVID-19 treatment advice; updates vaccine guidance for cancer patients
Leading cancer and infectious disease experts analyze latest data and FDA approvals to create evidence-based expert consensus recommendations for both treatment and prevention of COVID-19 for people with cancer
Read moreHPV vaccine may not be cost-effective in adult populations aged over 26 years
Study suggests vaccinating men and women aged over 26 years is expensive with limited health benefits
Read moreResearchers boost potency of an HIV-1 antibody, tracing new pathways for vaccine development
LAWRENCE — Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to
Read moreA containment laboratory 3 propels research on COVID-19 and other pathogens at INRS
The Institut national de la recherche scientifique (INRS) inaugurates today its new Level 3 laboratory (CL3), which propels research on
Read moreNew technology could increase health inequities
Making sure that everyone gets the benefits of new approaches to managing and treating disease
Read moreOutbreak of a rare, polio-like syndrome likely prevented, postponed by social distancing
Social distancing not only helped slow the spread of COVID-19 — it also may have prevented the transmission of an
Read moreSecond shot of COVID-19 vaccine may not be necessary in previously infected individuals — Mount Sinai
A single shot of one of the currently authorized COVID-19 vaccines may be sufficient to provide immunity to individuals who
Read moreHow the South African COVID-19 variant was found
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
Read morePhreesia partners with CONVINCE USA on vaccine hesitancy initiative
RALEIGH, N.C. & NEW YORK-Phreesia, the nation’s leading patient intake platform, is pleased to announce it has partnered with the
Read moreReal world data reveal risks of allergic reactions after receiving COVID-19 mRNA vaccines
Study provides reassurances of the vaccines’ safety
Read moreBig shift seen in high-risk older adults’ attitudes toward COVID-19 vaccination
Poll shows double-digit jumps since autumn in percentage of Black, Hispanic and chronically ill older adults who say they’ll get vaccinated — or already have
Read moreCapitalizing on measles vaccine’s successful history to protect against SARS-CoV-2
In animals, COVID-19 vaccine candidate prompts strong immune responses and prevents infection
Read moreSpacing COVID-19 vaccine doses has benefits, but longer-term outcomes depend on robust immunity
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and
Read moreDiphtheria risks becoming major global threat again as it evolves antimicrobial resistance
Diphtheria – a relatively easily-preventable infection – is evolving to become resistant to a number of classes of antibiotics and in future could lead to vaccine escape, warn an international team of researchers from the UK and India.
Read moreStudy of coronavirus variants predicts virus evolving to escape current vaccines
A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies
Read moreCOVID-19 vaccine candidate based on UCPH research ready for testing on humans
A few days from now the first human will be vaccinated with a Danish vaccine candidate against COVID-19. It is
Read moreWRAIR, Duke scientists find evidence of monoclonal antibodies activity against malaria
Scientists at Walter Reed Army Institute of Research, in a collaboration with Duke University, have confirmed that monoclonal antibodies can
Read more
SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells
The body’s immune response plays a crucial role in the course of a SARS-CoV-2 infection.
Read more
Rutgers University’s Resilient, Innovative Year Confronting COVID-19
The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.
Read moreMutant proteins from SARS-CoV-2 block T cells’ ability to recognize and kill infected cells
A deep sequencing study of 747 SARS-CoV-2 virus isolates has revealed mutant peptides derived from the virus that cannot effectively
Read moreSARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells
The body’s immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the
Read moreApproaches for optimal use of different COVID-19 vaccines
What The Article Says: This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants
Read moreEquitably allocating COVID-19 vaccine
Study sheds light on vaccine acceptance among sexual and gender minorities
Read more
More than 1,000 SARS-CoV-2 Coronavirus Protein 3D Structures Available
New Brunswick, N.J. (March 3, 2021) – The 3D structures of more than 1,000 SARS-CoV-2 coronavirus proteins are freely available
Read moreResearchers urge greater awareness of delayed skin reactions to Moderna COVID-19 vaccine
These reactions should not discourage patients from getting the vaccine, say researchers at Massachusetts General Hospital
Read moreSARS-CoV-2 immunization passports: A ticket to normal life?
Proof of immunization against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may soon be required in many parts of the
Read moreInfluenza vaccine produces protective antibodies against diverse flu strains in animals
A series of nanoparticle-based vaccines elicits protective antibodies against various strains of the influenza virus in nonhuman primates, according to
Read moreFAIR Health releases study on impact of COVID-19 on pediatric mental health
In March and April 2020, mental health claim lines for individuals aged 13-18, as a percentage of all medical claim lines, approximately doubled over the same months in the previous year.
Read moreThe implications of swollen lymph nodes following COVID-19 vaccination
Lymph nodes in the armpit area can become swollen after a COVID-19 vaccination, and this is a normal reaction that typically goes away with time.
Read moreNanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies
New Cleveland Clinic-led research published in mBio
Read moreFAIR Health releases study on impact of COVID-19 on pediatric mental health
The Impact of COVID-19 on Pediatric Mental Health: A Study of Private Healthcare Claims
Read moreCommon vaccine terms defined
FACULTY Q&A Throughout the pandemic, we’ve been bombarded with terms like vaccine schedule, variants, mRNA, and more. Kristin Klein, clinical professor
Read moreMarch SLAS Discovery explores COVID-19 drug therapies six months later
Oak Brook, IL – The March edition of SLAS Discovery features the cover article, “Therapeutic and Vaccine Options for COVID-19:
Read moreGlobally most pregnant women, mothers would get COVID-19 vaccine, vaccinate their children
Acceptance in US and Russia lags
Read moreBlack Americans report high levels of vaccine hesitancy
Hesitancy also high among Black health Care workers
Read moreAntibodies recognize and attack different SARS-CoV-2 spike shapes
The spikes on the SARS-CoV-2 virus, which causes COVID-19, change shapes; new research reveals ways that antibodies can recognize these different shapes and block the virus and informs the design of vaccines and antiviral therapies
Read moreHow SARS-CoV-2’s sugar-coated shield helps activate the virus
SARS-CoV-2, the virus that causes COVID-19, is coated with sugars called glycans, which help it evade the immune system; new research shows precisely how those sugars help the virus become activated and infectious and could help with vaccine and drug disc
Read moreReal-world effectiveness of COVID-19 vaccine – research by Clalit Research Institute
First large-scale peer-reviewed study of real-world effectiveness of COVID-19 vaccine by Israel’s Clalit Research Institute published in The New England Journal of Medicine
Read moreNew ONC, NLM funding supports data exchange and response to COVID-19 pandemic
INDIANAPOLIS — LOINC® at Regenstrief, an international health data standard critical to health information exchange, has received additional federal funding
Read more